Kylie Getz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Kylie Getz has a total of 54 co-authors. Here are the top co-authors by number of shared publications:
- Emily S. Barrett
Environmental and Occupational Health Sciences Institute, Rutgers University, Piscataway, USA
2 shared publications Zorimar Rivera-Núñez
Department of Biostatistics & Epidemiology, Rutgers School of Public Health, Piscataway, NJ, USA; Environmental and Occupational Health Sciences Institute, Rutgers University, Piscataway, NJ, USA
2 shared publications- Adana A. M. Llanos
Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY 10032, USA
1 shared publication - Adriana Ba De Resende
Rutgers, The State University of New Jersey, Environmental and Occupational Health Sciences Institute, Piscataway, New Jersey USA
1 shared publication - Alicia Legard
Environmental and Occupational Health Sciences Institute, Rutgers, The State University of New Jersey, Piscataway, New Jersey, USA
1 shared publication Amber Rockson
Department of Epidemiology, Mailman School of Public Health, Columbia University Irving Medical Center, New York, NY, USA
1 shared publication
Latest Publications
- 21 September 2023
- Published by Elsevier in Women's Health Issues
- Vol. 34 (1) , 51-58
Characteristics Associated With Physician Bias in Contraceptive Recommendations
- 21 September 2023
- Published by Elsevier in Women's Health Issues
- Vol. 34 (1) , 51-58
Characteristics Associated With Physician Bias in Contraceptive Recommendations
- Open Access
- 20 July 2023
- Published by Elsevier in Environmental Research
- Vol. 236 (Pt 1) , 116719
Assessment of personal care product use and perceptions of use in a sample of US adults affiliated with a university in the Northeast
- 20 July 2023
- Published by Elsevier in Environmental Research
- Vol. 236 (Pt 1) , 116719
Open AccessAssessment of personal care product use and perceptions of use in a sample of US adults affiliated with a university in the Northeast
- 7 March 2023
- Published by Wolters Kluwer Health in Journal of Occupational and Environmental Medicine
- Vol. 65 (7) , 573-579
Incidence and Predictors of COVID-19 Infection in Prison Healthcare Workers
Objective: The aim of the study is to assess the predictors of SARS-CoV-2 infection among correctional healthcare workers (HCWs). Methods: We conducted a retrospective chart review to describe the demographic and workplace characteristics of New Jersey correctional HCWs between March 15, 2020, and August 31, 2020, using univariate and multivariable analysis. Results: Among 822 HCWs, patient-facing staff had the highest incidence of infection (7.2%). Associated risk factors include being Black and working in a maximum-security prison. There were few statistically significant findings due to small total numbers (n = 47) that tested positive. Conclusions: Correctional HCWs’ challenging work environment creates unique risk factors for infection with the SARS-CoV-2 virus. Administrative measures taken by the department of corrections may have a significant role in curbing the spread of infection. The findings can help focus preventive measures for reducing the spread of COVID-19 in this unique population.
- 7 March 2023
- Published by Wolters Kluwer Health in Journal of Occupational and Environmental Medicine
- Vol. 65 (7) , 573-579
Incidence and Predictors of COVID-19 Infection in Prison Healthcare Workers
Objective: The aim of the study is to assess the predictors of SARS-CoV-2 infection among correctional healthcare workers (HCWs). Methods: We conducted a retrospective chart review to describe the demographic and workplace characteristics of New Jersey correctional HCWs between March 15, 2020, and August 31, 2020, using univariate and multivariable analysis. Results: Among 822 HCWs, patient-facing staff had the highest incidence of infection (7.2%). Associated risk factors include being Black and working in a maximum-security prison. There were few statistically significant findings due to small total numbers (n = 47) that tested positive. Conclusions: Correctional HCWs’ challenging work environment creates unique risk factors for infection with the SARS-CoV-2 virus. Administrative measures taken by the department of corrections may have a significant role in curbing the spread of infection. The findings can help focus preventive measures for reducing the spread of COVID-19 in this unique population.
- 28 February 2023
- Published by Elsevier in Environmental Research
- Vol. 225, 115597
Protective role of the placental efflux transporter BCRP/ABCG2 in the relationship between prenatal cadmium exposure, placenta weight, and size at birth
- 28 February 2023
- Published by Elsevier in Environmental Research
- Vol. 225, 115597
Protective role of the placental efflux transporter BCRP/ABCG2 in the relationship between prenatal cadmium exposure, placenta weight, and size at birth
- Open Access
- 16 October 2020
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 80 (23) , 5189-5202
Evolution of the Epigenetic Landscape in Childhood B Acute Lymphoblastic Leukemia and Its Role in Drug Resistance
Although B-cell acute lymphoblastic leukemia (B-ALL) is the most common malignancy in children and while highly curable, it remains a leading cause of cancer-related mortality. The outgrowth of tumor subclones carrying mutations in genes responsible for resistance to therapy has led to a Darwinian model of clonal selection. Previous work has indicated that alterations in the epigenome might contribute to clonal selection, yet the extent to which the chromatin state is altered under the selective pressures of therapy is unknown. To address this, we performed chromatin immunoprecipitation, gene expression analysis, and enhanced reduced representation bisulfite sequencing on a cohort of paired diagnosis and relapse samples from individual patients who all but one relapsed within 36 months of initial diagnosis. The chromatin state at diagnosis varied widely among patients, while the majority of peaks remained stable between diagnosis and relapse. Yet a significant fraction was either lost or newly gained, with some patients showing few differences and others showing massive changes of the epigenetic state. Evolution of the epigenome was associated with pathways previously linked to therapy resistance as well as novel candidate pathways through alterations in pyrimidine biosynthesis and downregulation of polycomb repressive complex 2 targets. Three novel, relapse-specific superenhancers were shared by a majority of patients including one associated with S100A8, the top upregulated gene seen at relapse in childhood B-ALL. Overall, our results support a role of the epigenome in clonal evolution and uncover new candidate pathways associated with relapse. Significance: This study suggests a major role for epigenetic mechanisms in driving clonal evolution in B-ALL and identifies novel pathways associated with drug resistance.
- 16 October 2020
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 80 (23) , 5189-5202
Open AccessEvolution of the Epigenetic Landscape in Childhood B Acute Lymphoblastic Leukemia and Its Role in Drug Resistance
Although B-cell acute lymphoblastic leukemia (B-ALL) is the most common malignancy in children and while highly curable, it remains a leading cause of cancer-related mortality. The outgrowth of tumor subclones carrying mutations in genes responsible for resistance to therapy has led to a Darwinian model of clonal selection. Previous work has indicated that alterations in the epigenome might contribute to clonal selection, yet the extent to which the chromatin state is altered under the selective pressures of therapy is unknown. To address this, we performed chromatin immunoprecipitation, gene expression analysis, and enhanced reduced representation bisulfite sequencing on a cohort of paired diagnosis and relapse samples from individual patients who all but one relapsed within 36 months of initial diagnosis. The chromatin state at diagnosis varied widely among patients, while the majority of peaks remained stable between diagnosis and relapse. Yet a significant fraction was either lost or newly gained, with some patients showing few differences and others showing massive changes of the epigenetic state. Evolution of the epigenome was associated with pathways previously linked to therapy resistance as well as novel candidate pathways through alterations in pyrimidine biosynthesis and downregulation of polycomb repressive complex 2 targets. Three novel, relapse-specific superenhancers were shared by a majority of patients including one associated with S100A8, the top upregulated gene seen at relapse in childhood B-ALL. Overall, our results support a role of the epigenome in clonal evolution and uncover new candidate pathways associated with relapse. Significance: This study suggests a major role for epigenetic mechanisms in driving clonal evolution in B-ALL and identifies novel pathways associated with drug resistance.